Speaker

Local Speakers

Dr. Adel El Assy

Senior Manager, Pharmaceuticals Supply Chain Management
M42, Abu Dhabi, UAE

Dr. Adel El Assy

Adel Al-Assy RPh is a seasoned pharmaceutical Revenue cycle, supply chain and procurement expert, currently serving as the Senior Manager of Pharmaceuticals Supply Chain Management at M42 in Abu Dhabi. With over a decade of experience in the healthcare industry, he has a proven track record of optimizing multi-million-dollar budgets, leading large-scale pharmaceutical tenders, and forging strategic partnerships with key industry stakeholders. Adel has also played a pivotal role in collaborating with health authorities to ensure medication availability across various healthcare settings. He holds an EMBA in Healthcare leadership, Bachelor’s degree in Pharmaceutical Sciences from the University of Alexandria and is a certified professional in revenue cycle and supply chain management.

Dr. Ahmad Chaker

R.Ph., EMBA, DPLA, BCSCP

Director of Ambulatory Pharmacy Cleveland Clinic Abu Dhabi

Dr. Ahmad Chaker

R.Ph., EMBA, DPLA, BCSCP

Ahmad Chaker is currently the Director of Ambulatory Pharmacy at Cleveland Clinic Abu Dhabi. Ahmad previously worked in multiple positions at Cleveland Clinic Abu Dhabi: Manager, Oncology Pharmacy Services; Manager, Sterile Preparation Center; Lead Pharmacist Automation; and Informatics. Before joining the Cleveland Clinic in Abu Dhabi, Ahmad worked at Al Mafraq Hospital in Abu Dhabi and The American Hospital in Dubai. He carries multiple certifications in the fields of sterile preparation, automation, project improvement, and leadership. Ahmad’s major areas of interest are process improvement, lean management, change management, sterile preparation compounding, pharmacy informatics, and automation. Ahmad has delivered multiple presentations and posters on sterile preparations, the clean room, automated dispensing cabinets, and pharmacy manpower benchmarks.

Dr. Hady Jerdak

Internal Medicine, Pulmonary Diseases, Sleep Disorders, Critical Care Consultant Harley Street Medical Center Abu Dhabi, UAE

Dr. Hady Jerdak

Dr. Hady started his education at the American University of Beirut (AUB) and finished his specialty in pulmonary diseases and sleep disorders in France at the University of Lille. He has a vast experience in Asthma, COPD and cancer of the lungs (diagnosis and management). He does flexible Bronchoscopies for the patients here at Harley Street Medical Centre. Dr. Hady is also a specialist in Sleep Disorders, Sleep Apnea, Insomnia, Narcolepsy, Pediatric Sleep Disorders and other problems that are sleep related. At Harley Street Medical Centre we have a fully fledged sleep lab where the patient can perform his/her sleep study in-house attended by a HAAD Licensed nurse.

Dr. Haider Shamsi

Health Economist and HTA Specialist Department of Health – Abu Dhabi

Dr. Haider Shamsi

Haider Shamsi is a Health Economist and HTA Specialist at the Department of Health – Abu Dhabi, where he leads the development of evidence-based policies and value-driven reimbursement frameworks. His expertise spans economic modeling, cost-effectiveness analysis, and strategic market access for innovative therapies. Haider also brings clinical insight as a pharmacist, enhancing the integration of health economics into real-world care. Previously, he worked at the UK’s National Institute for Health and Care Excellence (NICE), contributing to technology appraisals for pharmaceuticals, medical technologies, and highly specialised therapies. He is passionate about advancing health policy, improving patient access, and driving sustainable healthcare systems.

Dr. Mohammad Yousuf Abdulfattah

Sheikh Shakhbout Medical City Abu Dhabi, UAE

Dr. Mohammad Yousuf Abdulfattah

I have got my Bachelor Degree in Pharmacy from Ajman University , then my Master degree in clinical pharmacy from Queens University –Belfast .
I joined Mafraq Hospital in 2009 , then Sheikh shakhbout medical city 2019.
Worked in many areas including Inpatient and Outpatient Pharmacy, Oncology pharmacy, Drug Information Centre , IBD centre , quality and medication safety ,with Clinical pharmacy department , involved in Pharmacy and therapeutics committee , OFF label medication, and leading the pharmacy education programme.

Dr. Mona Thakre

Consultant Neurologist
Mediclinic Parkview Hospital
Dubai, UAE

Dr. Mona Thakre

Dr. Mona Thakre is a well experienced Neurologist with more than 20 years of experience to her credit in UAE and India. She had her basic MBBS and MD in medicine from Nagpur University, India and DM and DNB in Neurology from Bombay Hospital, Mumbai University, India. She has completed her Speciality Certificate in Neurology from Royal college of Physicians (UK) and is a Fellow of American Academy of Neurology(FAAN).

She has worked in Government hospital Rashid hospital as Senior Specialist for 10years and since last 7 years as Consultant and Head of Neuroscience department at Al Zahra Hospital which is a tertiary care hospital in Dubai. She is the elected Board member of Emirates Neurology Society. Her areas of interest: Multiple Sclerosis ,Headache Stroke, Epilepsy and Movement disorders. She is an active researcher and has numerous presentations in local and international conferences. She has published numerous papers in peer reviewed journals.

Dr. Najwa Al-Bustani

Consultant Neurologist Neurology, Neurological Institute
Cleveland Clinic Abu Dhabi

Dr. Najwa Al-Bustani

Dr. Najwa Al-Bustani, is a Neurology Consultant with special interest in Neuromuscular medicine and Neurology Residency program director in the Neurological Institute at Cleveland Clinic Abu Dhabi. She holds an academic position of a Clinical Assistant Professor of Medicine at Cleveland Clinic Lerner Collage of Medicine, Case Western Reserve University.

Dr. Al-Bustani received her medical degree from Sultan Qaboos University, Muscat, Sultanate of Oman. She completed her residency training in Neurology at McGill University, Montreal, Canada. Subsequently, she completed her fellowship in Clinical Neurophysiology, EMG Track, Neuromuscular Medicine at the University of Washington, Seattle, W.A., USA

Dr. Raya Zayadeen

MCP, MHQS, CPHQ, CPPS, CPHFH, BCPS

Vice President, Pharmacy and Therapeutics, Global Patient Care Platform,
UAE and Bahrain

Dr. Raya Zayadeen

MCP, MHQS, CPHQ, CPPS, CPHFH, BCPS

Raya Zayadeen is a healthcare executive with over 15 years’ leadership in pharmacy, medication safety, and quality improvement across leading healthcare systems in the UAE and Gulf. As Vice President of Pharmacy & Therapeutics at M42, she drives strategic transformation of pharmacy services spanning ambulatory, long-term care, maternity, and specialty facilities. She specializes in innovative models improving outcomes, patient safety, and financial efficiency. Raya holds an MSc in Clinical Pharmacy, an Executive MBA, and a Master’s in Healthcare Quality and Safety from Harvard Medical School. A CPHQ, CPPS, and BCPS, she is committed to advancing pharmacy as a pillar of patient-centered care.

Dr. Sara Al Dallal

President of Emirates Health Economics Society
Dubai, UAE

Dr. Sara Al Dallal

Dr. Sara Al Dallal, the founder and president of the Emirates Medical Association’s Emirates Health Economics Society is a Medical Doctor graduated from the UAE University College of Medicine and Health Sciences. She completed her internal medicine residency in Dubai Health Authority, and she holds a master's in health care management from Royal Colleges of Surgeons Ireland and a double master's degree on Health Policy and Health Economics from London School of Economics. She is currently holding the position of Senior Health Service Specialist in Dubai Health Authority.

Dr. Zeyad Elgamal

Founder of Tamrah Health
Abu Dhabi, UAE

Dr. Zeyad Elgamal

Zeyad Elgamal is a healthcare leader with over 20 years of experience spanning hospital and retail pharmacy, pharmaceutical industry, healthcare management, and education across three continents. He holds a master's in management from Harvard University and executive training from Harvard Kennedy School. A Pharm.D. graduate from the University of Colorado, he is a Certified Diabetes Educator, SCOPE-certified in obesity management, and holds Additional Prescribing Authority (APA). Zeyad serves as Lead Clinical Pharmacist at Cleveland Clinic Abu Dhabi and lectures at Imperial College London Abu Dhabi, Alameen University, and Alexandria University, contributing to the advancement of diabetes education and clinical practice.

International Speakers

Dr. Anas Hamad

PhD, MSc, RPh

Director of Pharmacy Dept, NCCCR Head of Med Safety/Quality Center, HMC Head of Pharmacy Research Center, HMC Clinical Associate Professor, QU Lead of HTA Project, NHS, MOPH Head of Medications Committee, QRCS Vice President & Director, ISPOR Qatar

Dr. Anas Hamad

PhD, MSc, RPh

Dr. Anas is currently the Director of Pharmacy Department at Qatar's National Center for Cancer Care & Research. He is the Head of Medication Safety & Quality Center and Head of Pharmacy Research Center at Hamad Medical Corporation's Pharmacy Executive Office. He holds a position at Qatar University as a Clinical Associate Professor of Clinical Pharmacy & Practice. He is chairing the Standing Committee on Medication Services at Qatar Red Crescent Society. He is also the Vice President & Director of ISPOR Qatar Chapter. In addition, he is leading the Health Technology Assessment and Innovation Regulation Project under the National Health Strategy in the Ministry of Public Health. Dr. Anas finished his BSc in Pharmacy at the University of Jordan. He obtained MSc in Clinical Pharmacy, International Practice & Policy from the University of London and PhD in Clinical Practice & Medication Use from King's College London. He also acquired an Executive Diploma in Health Services Management from GSM London. Furthermore, he completed the Executive Leaders Program with Qatar Leadership Centre. That is in addition to multiple postgraduate certificates in health technology assessment, supply chain management, human subjects research, quality management, health economics and outcomes research. Dr. Anas is an active researcher with several publications and conference proceedings. He is an Editorial Board Member at International Journal of Clinical Pharmacy and Review Editor at Frontiers in Oncology. He regularly speaks at local and international conferences. He is a member of both HMC's and QU's Institutional Review Boards in addition to the MOPH National Clinical Research Review Committee. Moreover, he is a member of various committees/boards focusing on pharmacy practice, medication use, cancer care, research, safety & quality, medical affairs, healthcare education, health economics, governmental tenders, clinical transformation, and health insurance.

Dr. Courtney B. Smith

Medication Safety & Compliance Specialist Regulatory and Accreditation | Specialty Pharmacy Services Penn State Health Milton S. Hershey Medical Center Pennsylvania, USA

Dr. Courtney B. Smith

Dr. Courtney Smith is a specialty pharmacist at the Penn State Health Milton S. Hershey Medical Center. During her time at the health system, she worked under the pharmacy’s rheumatology service as a clinical pharmacist, where she leveraged her diverse background in both traditional and alternative medicine to provide comprehensive disease state management and specialty medication education. At Penn State Health, she emphasizes the importance of empowering patients through education and active participation in their treatment plans. She was recently promoted to the Medication Safety & Compliance Specialist role at the specialty pharmacy, guiding the team to meet all regulatory, accreditation and safety standards. In 2023, Dr. Smith received the Certified Specialty Pharmacist Certificant (CSP) and Board-Certified Medication Therapy Management Specialist (BCMTMS) designations. She is the recipient of the Upsher-Smith and NASPA Excellence in Innovation Award 2024, the Pennsylvania Pharmacists Association “Top Ten under Ten” Award 2024, the Pharmacy Podcasts – “Pharmacy 50” #28 and #26 Most Influential Pharmacy Leader for 2023 and 2024, and the National Association of Specialty Pharmacy (NASP) First Time Faculty Speaker 2023.

Dr. Jacob Jolly

PharmD, MMHC, CSP

Head of Pharmacy, Vaalia Health
Tennessee, USA

Dr. Jacob Jolly

PharmD, MMHC, CSP

Jacob Jolly is an experienced pharmacy leader with a deep background in the specialty pharmacy marketplace, health systems, and strategy. He currently serves as Head of Pharmacy at Vaalia Health, where he is building technology-enabled solutions to support specialty medication adherence. He is also the founder of ResonateRx, a consultancy supporting pharmacy and life sciences organizations. With previous leadership roles at Vanderbilt University Medical Center and Blue Fin Group, Jacob has broad and deep experiences to shape his perspective on innovative, patient-centered access solutions.

Dr. Jill Paslier

CEO and Founder of both Specia LLC and Paslier Consulting LLC
Pennsylvania, USA

Dr. Jill Paslier

Dr. Jill Paslier is a specialty pharmacy expert and the CEO and Founder of both Specia LLC and Paslier Consulting LLC. Specia LLC focuses on developing specialty pharmacy workflows and training programs, while Paslier Consulting LLC provides consulting services for specialty pharmacy operations, accreditation, and medication safety. She has provided expertise to organizations such as the Institute for Safe Medication Practices (ISMP), Integral Healthcare Solutions (IHS), and MetaStar. Dr. Paslier earned her Doctor of Pharmacy (PharmD) from the University of Minnesota College of Pharmacy in 2014 and completed the ISMP International Safe Medication Management Fellowship in 2021. She holds certifications in Medication Safety, Lean Six Sigma Green Belt, Certified Specialty Pharmacist (CSP), and Google Project Management.

Dr. Jonathan Ogurchak

PharmD, CSP, CPHIMS

CEO, Zeal Specialty Pharmacy;
CEO, STACK
Pittsburgh, USA

Dr. Jonathan Ogurchak

PharmD, CSP, CPHIMS

Jonathan Ogurchak, PharmD, CSP, CPHIMS has spent over 16 years of experience across specialty pharmacies, professional associations, and educational institutions. He is the CEO and co-founder of Zeal Specialty Pharmacy, an independent rare-disease pharmacy that leverages technology to deliver exceptional experiences for patients, prescribers, and pharmaceutical partners. Jonathan is also the CEO of STACK, a software company that offers two platforms: STACK for management of pharmacy resources and OnQueue, a pharmacy workflow and clinical management solution. Jonathan serves as an adjunct faculty member at 25 schools of pharmacy and contributes as a Director on the Specialty Pharmacy Certification Board (SPCB).

Dr. Kasem S. Akhras

PharmD

CEO and Co-Founder of VantEdge Acces Illinois, USA

Dr. Kasem S. Akhras

PharmD

Dr Kasem Akhras is CEO and Co-Founder of VantEdge Access, a healthcare start-up company bringing over 30 years of global biopharmaceutical experience in Market Access, pricing, Commercialization and artificial intelligence (AI). He has led strategic access and Government AMairs functions for top 10 pharma companies and advised on due diligence for multi-million-dollar deals. Kasem is a published author on Market Access in emerging markets, rare diseases, and Gene Therapy commercialization. His work bridges strategy, policy, and data science to expand global access to advanced therapies. He is passionate about leveraging AI to drive smarter, faster access decisions across diverse healthcare systems.

Dr. Mohamed Hashish

MSc, MS, BCPS, BCMTMS, RPh

Specialty Clinical Pharmacist (Cardiology | Hepatology | Neurology) Specialty Pharmacy, Cleveland Clinic, Ohio, USA

Dr. Mohamed Hashish

MSc, MS, BCPS, BCMTMS, RPh

Mohamed Hashish, MSc, MS, BCPS, BCMTMS, RPh is an international speaker and Specialty Pharmacist at Cleveland Clinic, USA, with over 15 years of cross-continental experience in the United States and the Middle East. He holds master’s degrees in Pharmaceutical Technology and Pharmacoeconomics & Health Economics, and is Board-Certified in Pharmacotherapy and Medication Therapy Management. Specializing in rare and complex disease states, Mohamed also serves as an advisor to ASHP’s Section of Specialty Pharmacy Practitioners, shaping strategies on patient care, outcomes, and value in specialty pharmacy.

Mr. Philip Morisky

MBA

Chief Optimus, Adherence Cartography
California, USA

Mr. Philip Morisky

MBA

Philip Morisky is a developer, researcher, and visionary whose work is redefining the future of patient-centered care. As the architect of the BAS-8™ and Behavioral Fragility Score (BFS), he has pioneered tools that bring predictive precision and stability modeling into medication adherence, bridging science with practical impact. A steward of his father’s legacy in the MMAS, he carries forward a tradition of innovation while advancing it into new domains of behavioral insight. His leadership has fueled successful ventures rooted in intellectual rigor, always centered on patients, as he continues to chart new frontiers in adherence research and practice.

Speaker

Local Speakers

Dr. Adel El Assy

Dr. Ahmad Chaker

Dr. Hady Jerdak

Dr. Haider Shamsi

Dr. Mohammad Yousuf Abdulfattah

Dr. Mona Thakre

Dr. Najwa Al-Bustani

Dr. Raya Zayadeen

Dr. Sara Al Dallal

Dr. Zeyad Elgamal

International Speakers

Dr. Anas Hamad

Dr. Courtney B. Smith

Dr. Jacob Jolly

Dr. Jill Paslier

Dr. Jonathan Ogurchak

Dr. Kasem S. Akhras

Dr. Mohamed Hashish

Mr. Philip Morisky

JOIN US

DON’T MISS OUT TO REGISTER AND BE A PART IN SHAPING THE FUTURE OF

FOR MORE INFORMATION, CONTACT